Arcturus Therapeutics Holdings Inc. (ARCT) Social Stream
Arcturus Therapeutics Holdings Inc (ARCT) Price Targets From Analysts
Use the tables below to see what analysts covering Arcturus Therapeutics Holdings Inc think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 11 | $140 | $25 | $73.3 | $31.17 | 135.16% |
| 2021-11-16 | 10 | $140 | $27 | $78 | $31.17 | 150.24% |
| 2022-01-03 | 9 | $140 | $31 | $84.375 | $31.17 | 170.69% |
| 2022-01-24 | 8 | $140 | $31 | $79.571 | $31.17 | 155.28% |
| 2022-01-26 | 8 | $140 | $31 | $76.428 | $31.17 | 145.2% |
| 2022-02-28 | 8 | $140 | $31 | $76.428 | $31.17 | 145.2% |
| 2022-03-01 | 8 | $140 | $31 | $75.428 | $31.17 | 141.99% |
| 2022-03-23 | 8 | $140 | $25 | $74.285 | $31.17 | 138.32% |
The Trend in the Analyst Price Target
Over the past 44 weeks, ARCT's average price target has gone down $9.8.
ARCT reports an average of 132.35% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-05 | 9 | 160 | 23 | 81.850 | 30.74 | 166.27% |
| 2021-11-09 | 11 | 140 | 27 | 77.111 | 36.23 | 112.84% |
| 2021-12-09 | 9 | 140 | 31 | 84.375 | 36.35 | 132.12% |
| 2022-01-26 | 8 | 140 | 31 | 76.428 | 23.48 | 225.5% |
| 2022-02-28 | 8 | 140 | 31 | 76.428 | 23.97 | 218.85% |
ARCT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.5 | 4 | 0 | 2 | 2 | 2 | 8 |
The Trend in the Broker Recommendations
Over the past 18 months, ARCT's average broker recommendation rating worsened by 1.14.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, Arcturus Therapeutics Holdings Inc's variance in analysts' estimates is lower than -874.71% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Arcturus Therapeutics Holdings Inc's average analyst price target is higher than 962.1% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Arcturus Therapeutics Holdings Inc's number of analysts covering the stock is greater than 960.28% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Arcturus Therapeutics Holdings Inc's upside potential (average analyst target price relative to current price) is greater than 638.81% of them.
Stocks similar to Arcturus Therapeutics Holdings Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ARAV, AQST, and APTX.
Is ARCT a Buy, Hold or Sell? See the POWR Ratings now!